![Study Results & Research Projects Study Results & Research Projects](https://webarchive.library.unt.edu/web/20090202042512im_/http://ntp.niehs.nih.gov/images/template/subMastHead_studyResults.gif)
NTP Study Reports
NTP Study Reports
Home » Study Results & Research Projects » NTP Study Reports » All Long-Term Reports » Abstract for TR-509 - 2,4-Hexadienal
Chemical Formula: C6H8O
2,4-Hexadienal, a colorless to yellow liquid with a pungent "green" or citrus odor, is used as a food additive for flavor enhancement, as a fragrance agent, as a starting material or intermediate in synthetic reactions in the chemical and pharmaceutical industries, as a fumigant, and as a corrosion inhibitor for steel. 2,4-Hexadienal was nominated for study by the National Cancer Institute because of the potential for carcinogenicity based on its a,b-unsaturated aldehyde structure and the potential link between exposure to lipid peroxidation products in the diet and human malignancies. The commercial product is a mixture containing chiefly trans,trans-2,4-hexadienal in equilibrium with cis,trans-2,4-hexadienal. Male and female F344/N rats and B6C3F1 mice received 2,4-hexadienal (89% trans,trans; 11% cis,trans) in corn oil by gavage for 16 days, 14 weeks, or 2 years. Tissues and plasma from dosed rats were examined for malondialdehyde and glutathione concentrations, and DNA adducts were characterized in liver and forestomach samples from dosed rats and mice. Genetic toxicology studies were conducted in Salmonella typhimurium, rat and mouse bone marrow cells, and mouse peripheral blood erythrocytes.
Groups of five male and five female rats were administered 0, 3, 9, 27, 80, or 240 mg 2,4-hexadienal/kg body weight in corn oil by gavage, 5 days per week, for 16 days. Three male and three female 240 mg/kg rats died before the end of the study. Mean body weight gains of 240 mg/kg rats were significantly less than those of the vehicle controls. Clinical findings included diarrhea, ataxia, lethargy, and nasal/eye discharge in males, and lethargy, paleness, and abnormal breathing in females in the 240 mg/kg groups. Liver weights of 240 mg/kg females were significantly greater than those of the vehicle controls. Gross and microscopic lesions indicative of forestomach necrosis and ulceration were present in most 240 mg/kg rats, and forestomach epithelial hyperplasia was microscopically evident in most 80 mg/kg rats.
Groups of five male and five female mice were administered 2,4-hexadienal in corn oil by gavage at doses of 0, 3, 9, 27, 80, or 240 mg/kg, 5 days per week, for 16 days. Chemical-related deaths occurred in one male and one female in the 240 mg/kg groups. Female mice in the 240 mg/kg group lost weight during the study. Gross and microscopic lesions indicative of forestomach necrosis and ulceration were present in all 240 mg/kg mice, and forestomach epithelial hyperplasia and hyperkeratosis were microscopically evident in 80 mg/kg mice.
Groups of 10 male and 10 female rats were administered 2,4-hexadienal in corn oil by gavage at doses of 0, 7.5, 15, 30, 60, or 120 mg/kg, 5 days per week, for 14 weeks. All rats survived to the end of the study. Mean body weights of 30, 60, and 120 mg/kg males were significantly less than those of the vehicle controls. The only clinical finding attributed to 2,4-hexadienal administration was hypersalivation in 30 and 120 mg/kg males and females. The incidences of forestomach hyperplasia and nasal olfactory atrophy or necrosis were significantly increased in 120 mg/kg rats. Nasal lesions occurred in most 120 mg/kg male rats.
Groups of 10 male and 10 female mice were administered 2,4-hexadienal in corn oil by gavage at doses of 0, 7.5, 15, 30, 60, or 120 mg/kg, 5 days per week, for 14 weeks. No deaths were attributed to administration of 2,4-hexadienal. Mean body weights of males and females were similar to those of the vehicle controls throughout the study. Clinical findings included salivation and anal wetness in males and females. Kidney weights of 60 and 120 mg/kg males and liver weights of 60 mg/kg males and females were significantly greater than those of the vehicle controls. The incidences of forestomach hyperplasia and/or nasal olfactory atrophy or necrosis were significantly increased in 120 mg/kg mice.
Groups of 50 male and 50 female rats were administered 2,4-hexadienal in corn oil by gavage at doses of 0, 22.5, 45, or 90 mg/kg, 5 days per week, for up to 105 weeks. Survival of all dosed groups of rats was similar to that of the vehicle control groups. The mean body weights of 90 mg/kg males were generally less than those of the vehicle controls throughout the study.
The incidences of squamous cell papilloma of the forestomach occurred with positive trends in male and female rats. This neoplasm was found in 58% of males and 34% of females in the 90 mg/kg groups. In the forestomach of male rats, papilloma multiplicity was increased in the 90 mg/kg group, and squamous cell carcinomas were found in one 45 mg/kg male and two 90 mg/kg males. Epithelial hyperplasia of the forestomach occurred in most 45 and 90 mg/kg rats.
Groups of 50 male and 50 female mice were administered 2,4-hexadienal in corn oil by gavage at doses of 0, 30, 60, or 120 mg/kg, 5 days per week, for up to 105 weeks. Survival of dosed mice was similar to that of the vehicle controls. The mean body weights of all dosed groups were generally similar to those of the vehicle controls throughout the study. The incidences of squamous cell papilloma of the forestomach occurred with positive trends in male and female mice; squamous cell carcinomas were present in 120 mg/kg males and females. Epithelial hyperplasia of the forestomach occurred in many 120 mg/kg mice. Two 120 mg/kg males had uncommon squamous cell carcinoma of the oral cavity (tongue).
2,4-Hexadienal was mutagenic in S. typhimurium strain TA100 with and without induced hamster or rat liver enzymes; no mutagenic activity was detected with strains TA1535 or TA98, with or without S9. Results of bone marrow tests in male rats and male mice given intraperitoneal injections of 2,4-hexadienal showed a small increase in the induction of micronucleated erythrocytes. However, neither test was repeated, and the test results were judged to be inconclusive. Results of peripheral blood micronucleus tests in male and female mice treated with 2,4-hexadienal by gavage for 14 weeks were negative.
Under the conditions of these 2-year gavage studies, there was clear evidence of carcinogenic activity of 2,4-hexadienal in male and female F344/N rats and male and female B6C3F1 mice based on increased incidences of squamous cell neoplasms of the forestomach. The occurrence of squamous cell carcinoma of the oral cavity (tongue) in male B6C3F1 mice may have been related to the administration of 2,4-hexadienal.
Hyperplasia of the forestomach in male and female rats and mice was associated with administration of 2,4-hexadienal.
Synonyms: Hexa-2,4-dienal; 2,4-hexadienal; 2,4-hexadien-1-al; 2,4-Hx; 1,3-pentadiene-1-carboxaldehyde; 2-propylene acrolein; sorbaldehyde; sorbic aldehyde
Summary of the 2-Year Carcinogenesis and Genetic Toxicology Studies of 2,4-Hexadienal
Male |
Female |
Male B6C3F1 Mice |
Female |
|
---|---|---|---|---|
Doses in corn oil by gavage |
0, 22.5, 45, or 90 mg/kg |
0, 22.5, 45, or 90 mg/kg |
0, 30, 60, or 120 mg/kg |
0, 30, 60, or 120 mg/kg |
Body weights |
90 mg/kg group less than the vehicle control group |
Dosed groups similar to the vehicle control |
Dosed groups similar to the vehicle control |
Dosed groups similar to the vehicle control |
Survival rates |
37/50, 35/50, 33/50, 30/50 |
37/50, 39/50, 41/50, 31/50 |
44/50, 39/50, 44/50, 39/50 |
42/50, 37/49, 37/50, 39/50 |
Nonneoplastic effects |
Forestomach: epithelium, hyperplasia, (3/50, 19/50, 42/50, 50/50) |
Forestomach: epithelium, hyperplasia (2/50, 16/50, 37/50, 41/50) |
Forestomach: epithelium, hyperplasia, squamous (14/50, 7/50, 9/50, 26/50 |
Forestomach: epithelium, hyperplasia, squamous (4/50, 8/49, 12/50, 31/50) |
Neoplastic effects |
Forestomach: squamous cell papilloma (0/50, 3/50, 10/50, 29/50); squamous cell carcinoma (0/50, 0/50, 1/50, 2/50); squamous cell papilloma or carcinoma (0/50, 3/50, 11/50, 29/50) |
Forestomach: squamous cell papilloma (0/50, 1/50, 5/50, 17/50) |
Forestomach: squamous cell papilloma (2/50, 4/50, 5/50, 8/50); squamous cell carcinoma (0/50, 1/50, 0/50, 2/50); squamous cell papilloma or carcinoma (2/50, 4/50, 5/50, 10/50) |
Forestomach: squamous cell papilloma (2/50, 2/49, 11/50, 13/50); squamous cell carcinoma (0/50, 0/49, 0/50, 7/50); squamous cell papilloma or carcinoma (2/50, 2/49, 11/50, 18/50) |
Equivocal findings |
None |
None |
Oral cavity (tongue): squamous cell carcinoma (0/50, 0/50, 0/50, 2/50) |
None |
Level of evidence of carcinogenic activity |
Clear evidence |
Clear evidence |
Clear evidence |
Clear evidence |
Genetic Toxicology |
||||
Salmonella typhimurium gene mutations: |
Positive in strain TA100 negative in strains TA1535 and TA98 with and without S9 |
|||
Micronucleated erythrocytes |
||||
Rat bone marrow in vivo: |
Inconclusive |
|||
Mouse bone marrow in vivo: |
Inconclusive |
|||
Mouse peripheral blood in vivo: |
Negative |
|||
Report Date: October 2003
Pathology Tables, Survival and Growth Curves from NTP 2-year Studies
Target Organs & Incidences from 2-year Studies
You may link to the full technical report in pdf format ( Note: A print ready copy of the document is presented in Portable Document Format (pdf) which requires the Acrobat Reader plug-in -- download a free copy of the reader.)
Web page last updated on January 11, 2008
The National Institute of Environmental Health Sciences is one of the National Institutes of Health within the U.S. Department of Health and Human Services. The National Toxicology Program is headquartered on the NIEHS campus in Research Triangle Park, NC.